Augmedix Inc
NASDAQ:AUGX
Augmedix Inc
Cash from Operating Activities
Augmedix Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Augmedix Inc
NASDAQ:AUGX
|
Cash from Operating Activities
-$15.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
Veeva Systems Inc
NYSE:VEEV
|
Cash from Operating Activities
$911.3m
|
CAGR 3-Years
18%
|
CAGR 5-Years
24%
|
CAGR 10-Years
36%
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Cash from Operating Activities
$24.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Evolent Health Inc
NYSE:EVH
|
Cash from Operating Activities
$142.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Doximity Inc
NYSE:DOCS
|
Cash from Operating Activities
$179.6m
|
CAGR 3-Years
90%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
Cash from Operating Activities
$138.3m
|
CAGR 3-Years
2%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
See Also
What is Augmedix Inc's Cash from Operating Activities?
Cash from Operating Activities
-15.4m
USD
Based on the financial report for Dec 31, 2023, Augmedix Inc's Cash from Operating Activities amounts to -15.4m USD.
What is Augmedix Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
5%
Over the last year, the Cash from Operating Activities growth was 8%. The average annual Cash from Operating Activities growth rates for Augmedix Inc have been -2% over the past three years , 5% over the past five years .